Sodium valproic acid (VPA) has been reported to occasionally delay pub
ertal maturation in children. In the current study, we sought to estab
lish a valid animal model with which to further investigate the neuroe
ndocrinological sequelae of VPA administration. Male and female DBA/2J
mice were weaned at 2 weeks of age and administered either VPA (17-20
mg/kg/day) or control solution via drinking water. Animals were weigh
ed and sacrificed via decapitation at 4, 6, or 8 weeks of age. Testes
and ovaries were prepared for histological analyses. In addition, the
length of the left humerus bone from each animal was obtained as an in
dex of skeletal growth, and trunk blood was assayed for circulating fo
llicle-stimulating hormone (FSH) and prolactin (PRL). For males, testi
cular weights of the animals receiving VPA were significantly lower th
an those of control animals at all three sampling ages. No between-gro
up differences were found for body weight at any sampling age, and yet
the rate of skeletal maturation (as indexed by humerus length) was de
creased significantly for the VPA-treated males at an three sampling p
eriods. Additionally, while hormone levels did not consistently differ
, histological analyses of the gonadal tissue demonstrated significant
ly decreased rates of spermatogenesis at all sampling points for WA-tr
eated animals. For females, chronic VPA administration led to a signif
icant reduction in uterine weight at the 4 and 6 week sampling periods
, and yet by 8 weeks of age the uterine weights for the two groups did
not differ. Histological analyses of the ovarian tissue revealed that
both the density of atrial follicles and corpora lutea were significa
ntly less in VPA-treated animals after 4 weeks of treatment, but not a
fter 2 or 6 weeks of treatment. However, these results were not corrob
orated by differences in circulating FSH or PRL levels. Finally, altho
ugh body weight did not differ between the two groups at any sampling
period, humerus length was significantly less for the VPA-treated fema
les at the 4 week sampling period. These data indicate that chronic ad
ministration of VPA delays reproductive and skeletal maturation in gen
etically epilepsy-prone mice.